News
PACB
1.170
-1.27%
-0.015
Weekly Report: what happened at PACB last week (0803-0807)?
Weekly Report · 8h ago
Earnings Release: Here's Why Analysts Cut Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Price Target To US$2.29
Simply Wall St · 2d ago
Pacific Biosciences Earnings Call: Growth Amid Headwinds
TipRanks · 3d ago
PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut
NASDAQ · 4d ago
Canaccord Genuity Sticks to Their Buy Rating for Pacific Biosciences (PACB)
TipRanks · 4d ago
Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX)
TipRanks · 4d ago
Pacific Biosciences: It's Only Getting Worse
Seeking Alpha · 4d ago
PacBio CEO Christian Henry steps down, Mark Van Oene succeeds
TipRanks · 4d ago
Pacific Biosciences Of California Approves Restructuring Plan To Align With Strategic Initiatives; Restructuring To Reduce Workforce By About 8%; Expects $30M-$40M Annualized Operating Expense Reduction By End Of 2027; Estimates $2M Pre-Tax Charges For Reduction In Force
Benzinga · 4d ago
Pacific Biosciences of California Appoints New CEO, Plans to Cut 8% of Workforce
Dow Jones · 4d ago
PacBio reports Q2 EPS (14c), consensus (13c)
TipRanks · 4d ago
PacBio cuts FY26 revenue view to $155M-$165M from $165M-$175M
TipRanks · 4d ago
PacBio Restructures Operations and Appoints New CEO
TipRanks · 4d ago
PacBio appoints COO as new CEO
Seeking Alpha · 4d ago
*PacBio: Appoints Mark Van Oene as Pres and CEO >PACB
Dow Jones · 4d ago
Pacific Biosciences Lowers FY2026 Sales Guidance from $165.000M-$175.000M to $155.000M-$165.000M vs $166.790M Est
Benzinga · 4d ago
Pacific Biosciences of California Appoints Mark Van Oene As President, CEO, Effective Immediately, Succeeding Christian Henry
Benzinga · 4d ago
Pacific Biosciences of California Non-GAAP EPS of -$0.14 misses by $0.01, revenue of $39M misses by $1.58M
Seeking Alpha · 4d ago
Press Release: PacBio Appoints Mark Van Oene as President and Chief Executive Officer
Dow Jones · 4d ago
*Pacific Biosciences 2Q Rev $39M >PACB
Dow Jones · 4d ago
More
Webull provides a variety of real-time PACB stock news. You can receive the latest news about Pacific Biosc through multiple platforms. This information may help you make smarter investment decisions.
About PACB
Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops, and manufactures sequencing solutions. Its products and technology include HiFi long-read sequencing technology, which addresses a set of applications including human germline sequencing, plant and animal sciences, infectious disease, microbiology, oncology, and other applications. Its sequencing technology supports oncology research by enabling analysis of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), providing researchers with insight into cancer biology. It focuses on creating sequencing systems to provide customers with a view of genomes, transcriptomes, and epigenomes. Its customers include academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations (CROs), pharmaceutical companies, and agricultural companies.